Breaking News
Get 40% Off 0
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March. Read full update
Close

DBV Technologies (DBV)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.21 -0.01    -0.65%
10:19:00 - Real-time Data. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  France
ISIN:  FR0010417345 
  • Volume: 18,250
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 1.21 - 1.24
DBV Technologies 1.21 -0.01 -0.65%

DBV Recent Sentiments

 
This page contains information on users’ sentiments for the DBV Technologies stock, which are displayed both on charts of different periods of time and on a detailed table.
BearishBullish
Start Date Username Call Open Rate End Date Chg. %
May 03, 2024 Pascal Roure   1.22 -0.82%
May 03, 2024 Aurelien DI MEGLIO   1.20 +0.83%
Apr 24, 2024 RICHARD GORA   1.21 Apr 29, 2024 @ 1.24 -2.48%
Apr 23, 2024 Daniel Fernandez   1.23 -1.63%
Apr 17, 2024 saad saad   1.26 -3.97%
Apr 17, 2024 Sébastien DEJEAN   1.27 -4.72%
Apr 03, 2024 ben so   1.36 Apr 26, 2024 @ 1.19 -12.50%
Apr 02, 2024 ben so   1.36 Apr 03, 2024 @ 1.36 0.00%
Mar 27, 2024 severine pietrzak   1.33 Apr 19, 2024 @ 1.24 +6.77%
Mar 18, 2024 Daniel Fernandez   1.35 Apr 12, 2024 @ 1.26 -6.67%
Mar 12, 2024 saad saad   1.50 Apr 05, 2024 @ 1.38 -8.00%
Mar 11, 2024 Mario Cano Rebuelta   1.45 Apr 04, 2024 @ 1.38 -4.83%
Mar 11, 2024 ben so   1.42 Mar 28, 2024 @ 1.33 -6.34%
Mar 08, 2024 mi re   1.36 Mar 29, 2024 @ 1.33 -2.21%
Mar 04, 2024 Pascal Roure   1.39 Mar 29, 2024 @ 1.33 -4.32%
Feb 22, 2024 OLIVIER CAILLAU   1.40 Mar 15, 2024 @ 1.38 -1.43%
Feb 22, 2024   1.39 Mar 15, 2024 @ 1.38 -0.72%
Feb 20, 2024 assakour mohammadi   1.28 Mar 15, 2024 @ 1.38 -7.81%
Feb 19, 2024 Catherine korady   1.10 Mar 15, 2024 @ 1.38 +25.45%
Feb 19, 2024 Aurelien DI MEGLIO   1.10 Mar 15, 2024 @ 1.38 +25.45%
Feb 19, 2024 severine pietrzak   1.48 Feb 26, 2024 @ 1.43 -3.38%
Feb 16, 2024 Frédéric Dal Moro   1.67 Mar 08, 2024 @ 1.42 -14.97%
Feb 09, 2024 Jean Pierre Jaillet   1.58 Mar 01, 2024 @ 1.39 -12.03%
Jan 29, 2024 saad saad   1.79 Feb 23, 2024 @ 1.40 -21.79%
Jan 22, 2024 Pipa Forex   1.69 Feb 16, 2024 @ 1.68 +0.59%
Jan 22, 2024 mi re   1.65 Feb 16, 2024 @ 1.68 +1.82%
Jan 18, 2024 Laurent Zerat   1.73 Feb 09, 2024 @ 1.60 -7.51%
Jan 15, 2024 Pascal Roure   1.65 Feb 09, 2024 @ 1.60 -3.03%
Jan 10, 2024 Nathan Dias   1.74 Feb 02, 2024 @ 1.70 -2.30%
Dec 29, 2023 saad saad   1.92 Jan 19, 2024 @ 1.65 -14.06%
Dec 28, 2023 Olivier Desmet   1.98 Jan 19, 2024 @ 1.65 -16.67%
Dec 28, 2023 Damien Faurichon   2.03 Jan 19, 2024 @ 1.65 +18.72%
Dec 28, 2023 Aurelien DI MEGLIO   1.97 Jan 19, 2024 @ 1.65 -16.24%
Dec 27, 2023 ben so   2.00 Dec 27, 2023 @ 2.00 0.00%
Dec 27, 2023 Catherine korady   2.00 Jan 19, 2024 @ 1.65 -17.50%
Dec 27, 2023 Stéphane Valette   1.98 Jan 19, 2024 @ 1.65 -16.67%
Dec 27, 2023 Pipa Forex   1.94 Jan 19, 2024 @ 1.65 -14.95%
Dec 27, 2023 ben so   1.94 Dec 27, 2023 @ 1.94 0.00%
Dec 22, 2023 Nicolas COTTUS   1.78 Jan 12, 2024 @ 1.72 +3.37%
Dec 20, 2023 Pascal Roure   1.87 Jan 12, 2024 @ 1.72 -8.02%
Dec 20, 2023 Nico Nikill   1.87 Jan 12, 2024 @ 1.72 -8.02%
Dec 20, 2023 ben so   1.89 Dec 20, 2023 @ 1.89 0.00%
Dec 20, 2023 Hervé Comérot   1.89 Jan 12, 2024 @ 1.72 -8.99%
Dec 20, 2023 Noah Cornec   1.80 Jan 12, 2024 @ 1.72 -4.44%
Dec 20, 2023 severine pietrzak   1.82 Jan 12, 2024 @ 1.72 -5.49%
Dec 19, 2023 ben so   1.72 Dec 19, 2023 @ 1.72 0.00%
Dec 18, 2023 Daniel Gonin   1.76 Dec 25, 2023 @ 1.79 +1.70%
Dec 15, 2023 severine pietrzak   1.73 Dec 18, 2023 @ 1.72 -0.58%
Dec 15, 2023 ben so   1.69 Dec 15, 2023 @ 1.69 0.00%
Dec 15, 2023 ben so   1.69 Dec 15, 2023 @ 1.69 0.00%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

DBV Comments

Write your thoughts about DBV Technologies
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
João Catarino
João Catarino Feb 11, 2021 11:24AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://finance.yahoo.com/news/notice-media-covid-19-july-120000875.html?.tsrc=fin-srch
Krava Tsakosh
Krava Tsakosh Jan 18, 2021 8:21AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
FDA will approve it...
Krava Tsakosh
Krava Tsakosh Jan 18, 2021 8:21AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
DBV Technologies price target raised to $7 from $4 at Goldman Sachs. Goldman Sachs analyst Graig Suvannavejh raised the firm's price target on DBV Technologies (DBVT) to $7 from $4 and keeps a Buy rating on the shares after the company announced an update on the U.S. regulatory status of lead asset Viaskin Peanut. The stock closed Friday up 51% to $5.66. The analyst came away "increasingly positive" given the clarity gained on the forward, and continues to have confidence in the ultimate approvability of Viaskin Peanut in the U.S. and its commercial potential. Viaskin Peanut is the more attractive and easier product to administer relative to its main competition, Nestle's (NSRGY) Palforzia, Suvannavejh tells investors in a research note.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email